Biotech Insights – October 2026

In patent preparation practice, a common temptation for some is to cut corners on early filings by providing too low a provisional budget or insufficient time between disclosure and making a filing. Clients frequently push for a quick, low-cost “provisional” patent application to secure an early filing date before a conference presentation, publication or funding round. However, a recent Federal Circuit decision in Enanta Pharmaceuticals, Inc. v. Pfizer, Inc….
By: Haynes Boone

In patent preparation practice, a common temptation for some is to cut corners on early filings by providing too low a provisional budget or insufficient time between disclosure and making a filing. Clients frequently push for a quick, low-cost “provisional” patent application to secure an early filing date before a conference presentation, publication or funding round. However, a recent Federal Circuit decision in Enanta Pharmaceuticals, Inc. v. Pfizer, Inc….
By: Haynes Boone